Stobart Group Ltd (“STOB”) today announced interim results for the 6 months to 31 August 2019. CEO Warwick Brady highlights …
Amryt Pharma, the pharma company focusing on developing treatments for patients with rare and orphan diseases, has today announced a …
HarbourVest Global Private Equity (“HVPE”) today announced interim results for the 6 months to 31 July 2019. Director of Investment …
Stenprop has acquired two multi-let industrial estates in Glasgow and Wolverhampton for £7.1 million, the company announced to the market …
HarbourVest Global Private Equity Limited (“HVPE”) held a Capital Markets’ Day earlier in the year. We captured some highlights on …
The Supermarket Income REIT (LSE: SUPR) has purchased another Sainsbury’s supermarket, this time in Cheltenham, Gloucestershire, from Legal & General …
We recently interviewed Adam Thrower who heads up PCF Bank’s Savings Division. PCF Bank are part of PCF Group plc …
HarbourVest Global Private Equity Limited (“HVPE”) a closed-end investment company, listed on the London Stock Exchange, will announce its semi-annual …
iomart Group plc has today announced continued revenue growth in a trading update released to the market today. The results …
We recently interviewed Manuel Llobet and Nick Wykeman, CEO and CFO of AIM-listed Allergy Therapeutics following the announcement of the …
AIM-listed Amryt Pharma (LON: AMYT) has announced a major transactions which will significantly boost their presence in the market. The …
RBG Holdings this morning announced interim results for the 6 months ended 30 June 2019. We interviewed CEO Nicola Foulston …
iomart Group (AIM: IOM) posts another strong trading update for FY 2017. More here https://t.co/oKW0fbdzZC #iom #AIM #IHT #dividend
Inheritance tax: AIM is still saving the children https://t.co/zgsdJnclYL via @CityAM #AIM #IHT
Allergy Therapeutics (AIM: AGY) revenue growth, market share gain and clinical development. “2018 set to be a pivot… https://t.co/NlvEiN1e99
